Patent · US Active

Compounds

US7422749B2 · kind B2 · utility

0Cited by
17References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2007
Grant dateSep 9, 2008
Priority date
Expiry dateMar 24, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.